CRISPR News and Research

RSS
In the late 1980s and mid-1990s, genomes of diverse lineages of bacteria and archaea (the latter representing a domain of single-celled prokaryotic microorganisms) revealed clusters of regularly interspaced short palindromic repeats, known today under the abbreviation CRISPR. Later it was found that these repeat sequences (previously considered disparate) share a common set of features.
CNIO and HKUST researchers identify how some gliomas acquire chemoresistance

CNIO and HKUST researchers identify how some gliomas acquire chemoresistance

ALKBH5 enzyme shows promising target for cancer immunotherapy

ALKBH5 enzyme shows promising target for cancer immunotherapy

NIH invests $248.7 million in new COVID-19 testing technologies to meet U.S. demand

NIH invests $248.7 million in new COVID-19 testing technologies to meet U.S. demand

15 young scientists receive Damon Runyon Fellowship Award to pursue cancer research

15 young scientists receive Damon Runyon Fellowship Award to pursue cancer research

Olympus and Cytosurge collaborate to deliver a complete single-cell and CRISPR genetic manipulation solution in the Americas

Olympus and Cytosurge collaborate to deliver a complete single-cell and CRISPR genetic manipulation solution in the Americas

New strategy may help guard beta cells, slow the onset of type 1 diabetes

New strategy may help guard beta cells, slow the onset of type 1 diabetes

Olympus and Cytosurge collaborate to deliver a complete single-cell and CRISPR genetic manipulation solution in the Americas

Olympus and Cytosurge collaborate to deliver a complete single-cell and CRISPR genetic manipulation solution in the Americas

New genome-editing technologies can help understand disease-associated genetic mutations

New genome-editing technologies can help understand disease-associated genetic mutations

New strategy allows long-term, non-invasive tracking of cardiomyocytes

New strategy allows long-term, non-invasive tracking of cardiomyocytes

Vesigen Therapeutics to develop and commercialize novel drug-delivery technologies

Vesigen Therapeutics to develop and commercialize novel drug-delivery technologies

Newly identified enzyme provides a new tool in CRISPR genome editing toolbox

Newly identified enzyme provides a new tool in CRISPR genome editing toolbox

Study sheds new light on neurobiological processes that control drug-related adaptations

Study sheds new light on neurobiological processes that control drug-related adaptations

Researchers use gene-editing techniques to visualize protein action in multicellular animals

Researchers use gene-editing techniques to visualize protein action in multicellular animals

Horizon Discovery introduces Cas9 and dCas9-VPR stable cell lines to simplify and accelerate CRISPR gene editing workflows

Horizon Discovery introduces Cas9 and dCas9-VPR stable cell lines to simplify and accelerate CRISPR gene editing workflows

RNA plays key role in helping stem cells know what to become

RNA plays key role in helping stem cells know what to become

CityU develops CRISPR-assisted method to identify RNA-binding proteins in living cells

CityU develops CRISPR-assisted method to identify RNA-binding proteins in living cells

Researchers discover a protein that protects B cells from stress-induced cell death

Researchers discover a protein that protects B cells from stress-induced cell death

Salk Institute expands research to find treatments and cures for COVID-19

Salk Institute expands research to find treatments and cures for COVID-19

Study identifies small molecule inhibitors of SARS-CoV-2 which block key cellular kinases

Study identifies small molecule inhibitors of SARS-CoV-2 which block key cellular kinases

Noile-Immune Biotech and C4U team up to develop CRISPR/Cas3 technology

Noile-Immune Biotech and C4U team up to develop CRISPR/Cas3 technology